SUSAN BOCKMAN: Open Payments
NPI 1710266903 · CRYSTAL LAKE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 36 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $324 |
| GENZYME CORPORATION | 9 | $238 |
| CSL Behring | 3 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Amgen Inc. | 1 | $28 |
| BioCryst US Sales Co., LLC | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, Hizentra, CUVITRU, FASENRA, Rhapsido, BREZTRI.
Industry payments across IL — which companies pay providers there.
